QIAGEN IPA

QIAGEN Ingenuity Pathway Analysis CaseStudy_CD155 Expression in Metastatic Melanoma and Anti-PD1 resistance

891 views
October 14, 2020
In this video, Eric Seiser, Ph.D, Sr. Field Application Scientist will be demonstrating a use case of QIAGEN Ingenuity Pathway Analysis for interpreting the biology of gene expression based omics dataset. The focus will be on a recent study on a potential therapeutic target CD155 for Metastatic Melanoma patients that demonstrate resistance to Anti-PD1 based therapies

Related videos

QIAGEN IPA

Exploring COVID-19 implicated genes in QIAGEN IPA and OmicSoft Land Explorer

266,712 views April 01, 2020

Interested in learning more? Click here

QIAGEN IPA

Analyze, compare and contextualize your biological data with QIAGEN IPA

64,348 views June 07, 2023

Discover why QIAGEN Ingenuity Pathway Analysis (IPA) is more than just...

QIAGEN IPA

IPA Webinar: Part 1: Introduction to Ingenuity Pathway Analysis

38,527 views November 12, 2019

Learn how to quickly and easily identify significant pathways, discover...

QIAGEN IPA

IPA Webinar: Part 2: Formatting and Uploading Your Dataset into IPA

19,707 views November 12, 2019

IPA has broadly been adopted by the life science research community and is...